A comparison of long-term cost and clinical outcomes between the two-stage sequence expander/prosthesis and autologous deep inferior epigastric flap methods for breast reconstruction in a public hospital

Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
A Lagares-BorregoT Gomez-Cia

Abstract

Postmastectomy breast reconstruction involves the use of large amounts of hospital resources. This study provides comparative data on the clinical results and long-term economic costs of two methods of breast reconstruction in a public hospital. A prospective cohort study was performed to evaluate the costs incurred by delayed unilateral breast reconstruction performed using either the two-stage sequence expander/prosthesis (E-P) or autologous deep inferior epigastric flap (DIEP) method during 2005-2013 in 134 patients. The major evaluated variables included previous clinical records, history of radiotherapy, and number of surgical procedures. Total costs accounted for both direct intra- and extra-hospital costs derived from the initial reconstruction and those resulting from associated reoperations due to aesthetic retouches and/or complications. Patients undergoing E-P reconstruction required a higher number of surgery sessions to complete the reconstruction (3.07 vs. 2.32, p < 0.001) and showed higher rates of surgery-related complications (40.29% vs. 32.82%). No statistically significant differences were found between the two surgical methods in terms of total costs (€18857.77 DIEP vs. €20502.08 E-P; p = 0.89). In the E-P c...Continue Reading

References

Feb 1, 1996·Plastic and Reconstructive Surgery·S S KrollM A Schusterman
Jul 2, 2003·Plastic and Reconstructive Surgery·Scott L SpearJason C Ganz
Apr 15, 2004·Plastic and Reconstructive Surgery·Paul S GillRobert J Allen
Jun 30, 2005·Annals of Plastic Surgery·Susie J GoodwinBabak J Mehrara
Nov 21, 2007·The Breast : Official Journal of the European Society of Mastology·Veronique GuyomardMark Wilkinson
May 2, 2009·Plastic and Reconstructive Surgery·Amy K AldermanKevin C Chung
Jul 2, 2009·Plastic and Reconstructive Surgery·Emily S HuAmy K Alderman
Aug 1, 2009·Plastic and Reconstructive Surgery·Steven J Kronowitz, Geoffrey L Robb
Oct 1, 2010·Annals of Surgical Oncology·Tiffany BerryJill Dietz
May 28, 2011·Plastic and Reconstructive Surgery·Joseph M SerlettiLouis P Bucky
May 15, 2013·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·J T PagetS M Wilson
Feb 28, 2014·Plastic and Reconstructive Surgery·Claudia R AlbornozEvan Matros

❮ Previous
Next ❯

Citations

Nov 26, 2019·Plastic and Reconstructive Surgery·Jonas A NelsonAndrea L Pusic
Jan 10, 2020·Plastic and Reconstructive Surgery·Nicholas T Haddock, Sumeet S Teotia
May 23, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dean A ShumwayReshma Jagsi
Mar 19, 2020·Annals of Plastic Surgery·Daniel H ChenBao Ngoc N Tran
Jun 12, 2020·Medicina·David J RestrepoAntonio J Forte
Mar 30, 2020·Plastic and Reconstructive Surgery·Nicholas T Haddock, Sumeet S Teotia
Nov 28, 2019·Plastic and Reconstructive Surgery. Global Open·Ankur KhajuriaAfshin Mosahebi
Jan 14, 2021·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Linda TallrothStina Klasson
Oct 14, 2019·American Journal of Surgery·Patrick T HanggeBarbara A Pockaj
Dec 23, 2020·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·Casimir A E KouwenbergJan J Busschbach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.